FindTrial
Sign In

Carhart test for patients with hearing loss and disproportionately high loss of speech understanding

Carhart test for patients with hearing loss and disproportionately high loss of speech understanding

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037194
Enrollment
150
Registered
2025-07-07
Start date
2025-10-17
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Data acquisition: hearing aid or cochlear implant treatment

Interventions

Group 1: Group 1: Hearing aid users - As part of the hearing aid check during routine treatment, a pure-tone audiogram, Freiburg speech test and a questionnaire survey are carried out once. An additi

Sponsors

SRH Zentralklinikum Suhl GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Indication for hearing aid or CI treatment

Exclusion criteria

Exclusion criteria: age < 18 a

Design outcomes

Primary

MeasureTime frame
Determination of the incidence of threshold tone decay in a clinical population of (current or future) hearing aid users or cochlear implant candidates (pre-op) and users (post-op) For hearing aid wearers, the threshold tone decay is measured once during a routine visit. In the case of CI treatment, the threshold tone decay test is performed before and after the CI treatment during routine visits. The threshold tone decay test is used.—

Secondary

MeasureTime frame
Recording the effects of threshold tone decay on speech understanding—

Countries

Germany

Contacts

Public ContactDaniel Böger

SRH Zentralklinikum Suhl GmbH

studienzentrum-suhl.zs@srh.de03681 35-5016

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026